Me is in trouble. Once a hot Silicon Valley startup, the genetic testing company has been in free fall since a major data ...
Anne Wojcicki, the cofounder and CEO of 23andMe, now says her plan to take the genetic testing company private is its "the ...
Usually, introductory meetings with startup executives are perfunctory and fade to irrelevance within an hour. But I still ...
September 30, 2024) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into 23andMe Holding Co. (NASDAQ:ME) regarding whether the board of directors and the co-founder ...
All of 23andMe’s independent directors have resigned from its board in a rare move that marks the latest challenge for the ...
Me's entire board of directors resigned over cofounder and CEO Anne Wojcicki's ongoing plan to take it private.
All seven of 23andMe’s independent board members resigned in a stinging rebuke to a proposal by CEO Anne Wojcicki’s plans to to take the company private. Wojcicki, who has been trying to take the ...
Me is not doing well. Its stock is on the verge of being delisted. It shut down its in-house drug-development unit last month ...
Seven independent members of the company’s board resigned Tuesday, concluding that despite co-founder and CEO Anne Wojcicki’s ...